Abstract Objective To describe Norwegian pharmacies' involvement in diabetes care, to investigate pharmacists' views on future services and to investigate whether the recommendations in the Norwegian diabetes declaration for pharmacies have been implemented. Setting Hospital and community pharmacies in Norway. Method All 543 pharmacies in Norway, of which 511 were community pharmacies and 32 were hospital pharmacies, received a link to a web-based questionnaire. One pharmacist from each pharmacy was asked to complete the questionnaire. The questionnaire covered subjects ranging from the diabetes declaration and the pharmacists' views on which services the pharmacy should offer in the future, to demographic characteristics. Results In total 358 (66%) questionnaires were completed. The diabetes declaration was read by 37% of the pharmacists. Almost all pharmacies complied with the declarations' recommendations regarding glucose monitoring services. Twenty four percent of the pharmacies could offer medication reviews, and roughly 10% could offer screening for undiagnosed diabetes. Counseling on lifestyle issues was the least implemented recommendation. Eighty one percent of the pharmacists reported a wish to expand their services towards diabetes patients. Services in regard to glucose monitoring had the highest score, however the views on which services should be offered varied a great deal. Already performing a service increased the chance of the pharmacist being positive towards offering it. Conclusion Norwegian pharmacists report that they are involved in a wide range of diabetes related services, although only 37% report to have read the diabetes declaration. The pharmacists generally wish to actively support patients with diabetes, and further research should concentrate on identifying the areas where their involvement is most productive.
Introduction
The number of people affected by diabetes worldwide is increasing. Thus, the demand for health personnel able to support patients in managing lifestyle changes, medication use and glucose monitoring is also on the increase. Studies have shown that the most successful interventions for assisting diabetes patients are those in which several groups of health personnel cooperate to achieve the best possible care for the patient [1] [2] [3] . Pharmacists could be valuable assets to such a team, considering their focused training on medication use and their availability to patients [4] [5] [6] .
Extensive research worldwide explores possible and implemented pharmacy based services for diabetes patients [7] [8] [9] [10] [11] [12] [13] . These include educational programs in the pharmacies [7] [8] [9] , counseling on medication, glucose monitoring and lifestyle [10, 11] , and screening for undiagnosed type 2-diabetes [12, 13] . In Norway, only one brief report describing the Norwegian pharmacies' involvement in diabetes care has yet been published [14] . However, the Norwegian Diabetes Association's requests for pharmacy services are described in the Norwegian diabetes declaration for pharmacies [15] , see Box 1. Evidence as to the effectiveness of pharmacy involvement in diabetes care is at present not conclusive [16] .
In 2001, the Norwegian pharmacy system underwent a radical structural change [17] . All pharmacies were formerly independently owned, but from 2001 three pharmacy chains have dominated the pharmacy market, today owning more than 80% of the pharmacies [18] . The total number of pharmacies in Norway increased by 35% from 397 in January 2001 to 535 in January 2005 [19] , which resulted in more, but smaller pharmacies with fewer pharmacists per pharmacy. Because the pharmacies are not allowed to advertise prescription drugs, the increased number of pharmacies has not led to large discounts or lower prices; instead, the pharmacies mainly compete by offering improved availability and services [20] . Extended services, and services earlier reserved for general practitioners' offices, are now advertised from pharmacies. Several of these are for patients with diabetes; blood glucose measurements, screening for diabetes, and control of the patients' self monitoring of blood glucose (SMBG) technique. However, there is no overview of all diabetes services offered by Norwegian pharmacies, and no data on how common these services are. General practitioners in particular have been skeptical of the introduction of such services in the pharmacies [21] .
In order to discuss and evaluate the role of the pharmacy in relation to patients with diabetes, it is necessary to know what is being done by the pharmacies today.
Aim of the study
The aim of this study has been to describe Norwegian pharmacies' involvement in diabetes care, to investigate pharmacists' views on future services and to find out ifand to what extent-the recommendations in the Norwegian diabetes declaration have been implemented.
Methods

Questionnaire development
A joint declaration called ''The role of the Norwegian pharmacies in the prevention and treatment of diabetes'' (the diabetes declaration) was published in 2001 by the Norwegian Diabetes Association (NDA), the Norwegian Pharmacy Association (NAF), and the Interest Group Diabetes in the Pharmacy (IDA, an independent diabetes interest group for pharmacy personnel) [15] . Here they present their recommendations on how pharmacies should engage in diabetes care (see Box 1).
Box 1 Summary: The role of the pharmacy in the prevention and treatment of diabetes. From the Joint declaration from the Norwegian Diabetes Association [15] 1. Collaboration with the health service and the Norwegian Diabetes Association at both central and local levels to prevent and treat diabetes.
2. Guidelines regarding the work and routines in the pharmacy, inclusive the development of expertise and updates on knowledge about diabetes.
3. Give advice and guidance in the use of medicines, contribute to ensure that medicines are used as prescribed and make sure that people with diabetes understand the aim of the treatment.
4. Follow up individuals who use medicines, identify medicine-related problems and resolve these in cooperation with the individual concerned and the doctor responsible for the treatment.
5. Give advice on the choice and use of diabetes material suited to individual needs.
6. Give advice and guidance on measuring blood glucose and interpreting the results. 7. Cooperate in order that motivation for treatment of diabetes is strengthened and maintained. Contribute to ensure the best possible proficiency in mastering the disorder.
8. Encourage those at risk to contact a doctor.
9. Contribute with information about the importance of lifestyle regarding development of diabetes and the prevention of late complications.
10. Provide information about the Norwegian Diabetes Association, encourage people to join the association and utilise the association's various sources of information and activity schemes.
The topics in the questionnaire were based on the diabetes declaration [15] , on dialogue with one pharmacist, two pharmacy technicians, and with the leader of the Diabetes centre in Bergen. To include as many relevant aspects of diabetes and the related services as possible, the questionnaire was piloted on 15 pharmacists known to be active in the field of diabetes. A research group consisting of general practitioners as well as the scientific directors of the three major pharmacy chains in Norway were then asked to comment on the questionnaire. Their replies as well as those of the pilot group were used to establish face and content validity of the questionnaire.
The 40-item questionnaire contained five sections: (I) Demographics of the pharmacist and the pharmacy, (II) Diabetes awareness and training of pharmacy personnel (covering statements 1-2 in the diabetes declaration), (III) Services offered by the pharmacy to the diabetes patient (statements 4-6), (IV) Issues for counseling (statements 3, 7-10) and (V) Pharmacists' views on a range of potential services that the pharmacy could provide. Both open ended and closed questions were used. A copy of the questionnaire (in Norwegian) is available from the authors.
Setting and sample
A web-based questionnaire was used. All 543 pharmacies in Norway, including both community (N = 511) and hospital pharmacies (N = 32), were sent a letter inviting them to take part in the study during the summer of 2005, as well as an email with a link to the web-based questionnaire. The website was not protected, but the letter contained an identification number unique to each pharmacy, and only replies with valid identification numbers were included in the analysis. One pharmacist from each pharmacy was invited to answer, preferably the pharmacist responsible for diabetes services in the pharmacy. If the pharmacy did not have a dedicated ''diabetes pharmacist'', the letter requested that either the ''information pharmacist'' (the pharmacist in charge of keeping the pharmacy staff professionally ''up to date'') or the managing pharmacist complete the questionnaire. It was also possible to print the questionnaire and return it by mail in a pre-paid envelope. Respondents were encouraged to contact the head of the study (RLSK) should they have any questions regarding the questionnaire. After two weeks all pharmacies were sent an e-mail reminder. Six weeks later, the nonresponders were contacted by phone to ensure that they had received the letter and the email. If they expressed a reason for not responding, this was noted, but not asked for. No further non-respondent analysis was carried out. The study did not require approval from the national ethics committee, but it was approved by the Norwegian Social Science Data Services (NSD).
Statistical analysis
Percentages are given without decimals. Where percentages do not add up to 100, this is due to missing values. Descriptive statistics for the continuous variables are expressed as either the mean and confidence intervals (CI), or as the mean/median and range, while categorical variables are expressed as frequencies and/or percentages.
The ''busyness'' of the pharmacists was estimated as number of prescriptions per pharmacist per opening hour, as an attempt to estimate how much of the pharmacists' time needed to be devoted to drug dispensing. Hospital pharmacies were omitted from this busyness analysis because they often have pharmacists employed in functions that do not involve dispensing of drugs.
Unless otherwise specified, crosstabs and Persons chi squared were used to test for significant effects. Busyness, number of employees and the staff having read the diabetes declaration or attended CPE courses were tested for effect on whether services were offered. However, as no significant effects were found (p was larger than 0.05 in all tests), the results of the tests are not reported in the ''Results'' section of this paper. Similarly, position at the pharmacy, education, graduation year and customer contact time were all found not to have any statistically significant effect on counseling.
All statistical analyses were performed using SPSS 13.0 for Windows.
Results
Sample
After the first reminder, the number of non-respondents was 300. After the follow-up call, a total of 358 pharmacists (response rate 66%) had returned the questionnaire, either the web-based version (91%), or by mail. During the followup calls, the most frequent reason stated for not responding was lack of time, due to limited staffing at the pharmacies.
The characteristics of the responding pharmacists are reported in Table 1 . Pharmacies filled an average of 5,073 prescriptions during April of 2005 (range 593-17,548). The number of employees varied from 2 to 80, the mean being 9.8. Opening hours was on average 46 h per week (range 25-107 h), and 75% of the pharmacists worked full time (80-100 % of 37.5 h per week). ''Busyness'' of the pharmacists for the community pharmacies varied from 1 to 39 prescriptions per pharmacist per hour.
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Of the responding pharmacists, 89% stated that their pharmacy staffed personnel with a special responsibility for diabetes related matters. The Norwegian diabetes declaration recommends that the pharmacies collaborate with the Norwegian Diabetes Association (NDA) (Box 1), and 81% of our sample were members of the NDA. However, only 19% were members of the Interest Group Diabetes in the Pharmacy (IDA). When asked if they were familiar with the diabetes declaration, 38% of the responders had read it; another 40% knew of it but had not read it, and the remaining 22% had never heard of it. The Norwegian diabetes declaration recommends that pharmacies have internal guidelines for the development of expertise and updates of diabetes knowledge. In 77% of the pharmacies, one or more pharmacists had taken part in external continuing professional education (CPE) diabetes courses during the previous two years, while for pharmacy technicians the percentage was 70. When asked if internal meetings/courses about diabetes were arranged by the pharmacies for their staff, 17% answered ''no,'' 17% answered ''yes, at least once per year,'' and 65% answered ''yes, but not regularly.'' Services offered to diabetes patients The diabetes declaration recommends that the pharmacies ''give advice on the choice and use of diabetes material'' and ''give advice and guidance on measuring blood glucose and interpreting the results'' (Box 1). Among the most commonly offered services were those related to the patients' SMBG measurements, where 99% of the pharmacies could offer help in choosing the right blood glucose monitoring device, and 95% could offer training in correct use of the device. Training in how to interpret the results correctly was less common; only 54% could offer this service.
While 51% of the respondents offer control of the patients' SMBG devices, only 37% do it by using either a reference instrument (6%), commercial control materials (21%), or both (10%). It is not known how the remaining 14% perform the control. Of the 131 pharmacies who offer control by a reference instrument or control materials, 32% have written standard operating procedures for this, and 17% charge a fee for the service.
The Norwegian diabetes declaration also recommends that the pharmacies ''follow up individuals who use medicines, identify medicine-related problems and resolve these in cooperation with the individual concerned and the doctor responsible for the treatment''. Medication reviews are offered by 24% of the pharmacies (Table 2) . For further services offered to patients with diabetes, see Table 2 .
Neither busyness, number of employees nor the staff having read the diabetes declaration or attended CPE courses had any significant effect on the services offered (p [ 0.05).
Counseling customers with diabetes
The diabetes declaration recommends that pharmacies give advice on the use of medicines and provide information about the importance of lifestyle in regard to the The diabetes declaration states that pharmacies should encourage those at risk to contact a doctor, and also that they should encourage people to join the NDA. Only 2% of the responders have never recommended that patients contact their general practitioner, and 9% have never recommended their patients to contact the NDA. In comparison, 18% have never recommended contact with a chiropodist, and 37% have never referred patients to an ophthalmologist.
The pharmacists' views on extended pharmacy services Eighty-one percent of the pharmacists thought the pharmacies' services for customers with diabetes should be expanded. The pharmacists were also asked to what extent they agreed that the pharmacy should offer a sample of 12 different services (Table 4) ; some diabetes specific, some general. The means were first calculated for all the pharmacists, and then the pharmacists were divided into groups depending on whether their pharmacy offered the service or not. Counseling on medication use and control of glucometers had the highest score, while the respondents were indifferent to the question of providing diabetes courses, performing blood glucose measurements and giving dietary advice. The pharmacists disagreed slightly that smoking cessation courses and blood pressure measurements should be offered, and strongly disagreed that the pharmacy should offer measurements of bone density, cholesterol, or INR, as well as screening for diabetes and dieting courses. However, there was great variation in the responses, and the entire scale from 1 = totally disagree to 9 = totally agree was used for all 12 services. Also, pharmacists working at pharmacies where a service was already offered scored significantly higher (independent samples test, equal variances not assumed) than those working at pharmacies that did not offer them ( Table 4 shows the 95% confidence intervals for the means).
Discussion
As recommended in the St Vincent declaration [22] , there are several national documents and guidelines covering diabetes care in Norway [23, 24] . However, the diabetes declaration from the NDA is the only one that mentions the role of the pharmacy. Therefore, although it is not a binding guideline, it is an important document for the pharmacies. As 62% of the respondents reported not to have read the diabetes declaration, it has not been successfully distributed among pharmacists. When investigating Scottish practitioners' agreement with the ''Guidelines for Community Pharmacists on the Care of Patients with Diabetes'', Stewart reports even lower numbers; 43% of the pharmacists had heard of the guidelines, but only one fourth of these had received a copy of them [25] .
Despite the relatively low knowledge of the declaration, many of the recommendations are implemented by some or all pharmacies. Practically all the pharmacies offer help with SMBG and choice of instruments for SMBG. Personnel especially responsible for diabetes services, membership in the NDA and high attendance at external courses about diabetes, indicates that the pharmacies view diabetes care as an important part of their work.
In this study, 24% of the pharmacies offered medication reviews. However, it is not known how, or how often, they actually perform these reviews for diabetes patients. There may be different views on what the term ''medication review'' signifies, as this was not defined in the questionnaire. This may also be the case in the many studies that have been published on pharmacists offering medication reviews to diabetes patients and to other patient groups [9, [26] [27] [28] [29] . In Australia [30] and the United Kingdom [31] pharmacies are reimbursed for medication reviews. 
Medication issues
How to take medication 5 (3-7) Adverse effects of medication 4 (2-6)
Adjusting their medication depending on the blood glucose value 2 (1-5)
Lifestyle issues
The importance of diet 4 (2-7)
The importance of exercise 3 (1-7)
Adjusting diet or exercise depending on the blood glucose value
Use of alcohol 2 (1-4)
How often do you discuss the following topics with your diabetes customers? (1 = never, 9 = always) (342 \ n £ 353) Pharm World Sci (2008) 30:191-198 195 Despite a growing awareness of the importance of lifestyle changes to prevent morbidity and mortality in diabetes [32] , these recommendations were the least implemented at our sample pharmacies (Table 3) . The low rate of counseling on lifestyle found in our study is in line with findings in Scottish and American studies [33, 34] . Heaton and Frede found that physicians insufficiently counsel and educate patients about the need for lifestyle changes, and conclude that pharmacists could perhaps contribute to filling this void [35] . However, Kotecki et al. reported constraints while working, lack of reimbursement for health promotion activities, physical design of the pharmacy and lack of information and/or training as important barriers to integrating health education and promotion activities into daily pharmacy practice [34] , and it is plausible that some-or all-of these reasons apply to Norwegian pharmacists as well. Schapansky used the Diabetes Attitude Scale to measure American pharmacists' attitudes towards diabetes, with the assumption that intentions are the best predictor of behavior. These pharmacists revealed a neutral attitude toward type 2-diabetes as a serious disease, and the researcher concludes that this may result in a lower caliber of care for these patients [5] . If the same is true for the Norwegian pharmacists, this may partly explain why they less frequently discuss the lifestyle issues relevant to the treatment of type 2-diabetes.
The data collected in this study shows that Norwegian pharmacists are very interested in working with diabetes patients. New projects and studies should consider choosing areas of work that pharmacists regard positively, such as blood glucose monitoring services or medication counseling.
We also find that the only document providing guidelines on how the pharmacies should be involved in diabetes care is not successfully distributed and implemented. An updated version of the Norwegian diabetes declaration should therefore be considered. Since the pharmacy chains to a large extent decide what services the individual pharmacies should offer, it is important for the scientific directors of the pharmacy chains to be involved in such an update. This would also help ensure the distribution and implementation of guidelines. The authors should use the available data from studies in other countries when deciding which areas of diabetes care the pharmacies should be involved in, and choose areas that have a documented effect on patient health.
Methodological limitations
In this study, the response rate was 66%. This compares well with similar studies in other countries, which have reported response rates from 31% to 65% [5, 33, 36, 37] . We find that while our responding pharmacies had a mean of 9.8 employees, the Norwegian national mean was 9.0 [19] . The mean monthly number of prescriptions in our study was 5,073, the national mean was 5,394. Our data therefore seems representative for the national mean in terms of pharmacy size. A possible significant bias could be that those most interested and active in the area of diabetes will be more inclined to answer the questionnaire, which could lead to an overestimation of the pharmacies' activities. To what extent do you agree that the pharmacy should offer the following services? (1 = totally disagree, 9 = totally agree) The means were first calculated for all the pharmacists (Total), and then the pharmacists were separated in to groups depending on whether their pharmacy offered the service (A) or not (B) a significant differences (independent samples test, equal variances not assumed)
Measuring frequency of counseling by a retrospective questionnaire has the weakness of recall bias. However, in our study we tried to establish whether some topics came up more often than others, and whether some topics were avoided all together, rather than try to measure exact counseling frequency. Also, because we only have answers from one pharmacist per pharmacy; our counseling frequencies may not reflect what the typical diabetes patient experiences at his or her visit to the pharmacy. As we are asking the ''diabetes experts'' in the pharmacy, our frequencies are most likely somewhat overestimated.
The study would have benefited from a triangulation of data, either through patient interviews or through dialogue with strategy makers in the three major pharmacy chains in Norway, to crystal-ball future diabetes services.
Deciding whether or not Norwegian pharmacies should be involved in diabetes care would require an assessment of the effects of the pharmacies' involvement, as well as an insight into the views of the diabetes patients on this matter. This goes beyond the scope of this paper. However, in light of the findings of this study, it would seem pertinent that this be done to ensure that Norwegian pharmacies' resources are employed in the best possible way for patients with diabetes.
Conclusion
Norwegian pharmacies are involved in a broad range of services for patients with diabetes, and also wish to expand services in this field. Diabetes services offered varies greatly between pharmacies. The Norwegian diabetes declaration has not been successfully distributed and integrated into the pharmacies' routines, but the pharmacies have implemented several of its' recommendations. Further research is needed to assess the effects and possible benefits of the pharmacies' services towards diabetes.
